Pay for Performance and Public Reporting: Risks to Patients Outweigh Benefits (Essay) Pay for Performance and Public Reporting: Risks to Patients Outweigh Benefits (Essay)

Pay for Performance and Public Reporting: Risks to Patients Outweigh Benefits (Essay‪)‬

Journal of American Physicians and Surgeons 2009, Winter, 14, 4

    • $5.99
    • $5.99

Publisher Description

Introduction Governments face pressures from increased entitlement spending on Medicare and Medicaid, and private firms from the cost of employee benefits. Centrally designed and implemented pay for performance (PFP) and public reporting (PR) programs (PFP/PR) are proposed as a solution to perceived quality gaps (1) as well as excess spending, by groups such as the Institutes of Medicine (IOM) and the Institute for Healthcare Improvement (IHI). It is frequently asserted that 100,000 Americans die every year from medical errors and receive only 50% of "appropriate" medical care, while paying excessively. (2)

GENRE
Business & Personal Finance
RELEASED
2009
22 December
LANGUAGE
EN
English
LENGTH
22
Pages
PUBLISHER
Association of American Physicians and Surgeons, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
283.4
KB

More Books by Journal of American Physicians and Surgeons

Conviction Without a Crime: A True Story (Viewpoint Essay) Conviction Without a Crime: A True Story (Viewpoint Essay)
2008
Selective Serotonin: Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?(Report) Selective Serotonin: Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?(Report)
2009
Point/Counterpoint: The Case Against Bioidentical Hormones (Drug Overview) Point/Counterpoint: The Case Against Bioidentical Hormones (Drug Overview)
2008
The Need for Clinical Judgment in the Diagnosis and Treatment of Lyme Disease (Report) The Need for Clinical Judgment in the Diagnosis and Treatment of Lyme Disease (Report)
2009
Tactics Characteristic of Sham Peer Review (Editorial) Tactics Characteristic of Sham Peer Review (Editorial)
2009
Study of Chelation Therapy should Not be Abandoned. Study of Chelation Therapy should Not be Abandoned.
2009